Skip to main content

Table 2 Treatment responses at day 28 after PCR correction for the first episode in the intent-to-treat patient populationa

From: Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial

Treatment response ASAQ AL Total
  Number (%)
Overall population (n = 184) (n = 182) (n = 366)
   Late clinical failure 0 (0.0) 3 (1.6) 3 (0.8)
   Late parasitological failure 1 (0.5) 2 (1.1) 3 (0.8)
   Adequate clinical and parasitological response 181 (98.4) 175 (96.2) 356 (97.3)
   Not applicable 2 (1.1) 2 (1.1) 4 (1.1)
<12 years old (n = 101) (n = 100) (n = 201)
   Late clinical failure 0 (0.0) 3 (3.0) 3 (1.5)
   Late parasitological failure 1 (1.0) 1 (1.0) 2 (1.0)
   Adequate clinical and parasitological response 98 (97.0) 95 (95.0) 293 (96.0)
   Not applicable 2 (2.0) 1 (1.0) 3 (1.5)
12 years old (n = 83) (n = 82) (n = 165)
   Late parasitological failure 0 (0.0) 1 (1.2) 1 (0.6)
   Adequate clinical and parasitological response 83 (100.0) 80 (97.6) 163 (98.8)
   Not applicable 0 (0.0) 1 (1.2) 1 (0.6)
  1. aAll randomized patients receiving at least one dose of study drug (patients vomiting twice after receipt of first dose were excluded).